Atlas Trials

WeDosify Real World Evidence (RWE) Study: Personalized Semaglutide Dosing in U.S. Adults

Clinical trial NCT07216651 · COMPLETED

Trial details

NCT number
NCT07216651
Sponsor
Closed Loop Medicine
Status
COMPLETED
Study type
OBSERVATIONAL
Obesity & Overweight
Start date
2025-09-23
Primary completion
2026-02-27
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.